eResearchTechnology Announces Extended Agreements With Two Key Customers Totaling $3.1 Million for EDC and Clinical Data Applica
24 February 2004 - 1:01AM
PR Newswire (US)
eResearchTechnology Announces Extended Agreements With Two Key
Customers Totaling $3.1 Million for EDC and Clinical Data
Applications Technology and Services New Commitments Signed with
Siemens and a Major Division of a Global Pharmaceutical Company
PHILADELPHIA, Feb. 23 /PRNewswire-FirstCall/ --
eResearchTechnology, Inc. (eRT) , a leading e-research technology
and services provider, announced today that agreements were
accepted in the past 30 days totaling $3.1 million with Siemens
Medical Solutions and the U.S.-based division of a major global
pharmaceutical organization that extend the ability for these
organizations to leverage eRT's EDC system and clinical data back
office application suite across their respective enterprises. The
agreements bring the total commitments to date from these
organizations for eRT's clinical data technology and services
solutions to more than $5 million. The latest agreements further
extend the customers' access to eRT's entire application solutions
offering,including its Enterprise Electronic Data Capture (EDC)
platform, eResearch Community portal, and eResearch Network
integrated back office suite, which features clinical data
management, trial management and monitoring, and adverse event
management and reporting solutions. "These exciting agreements
represent key milestones in the roll-out of eRT's entire offering
of clinical data technology solutions and services by segment
leaders in the global pharmaceutical and healthcare industries,"
said Scott Grisanti, senior vice president of business development
and chief marketing officer at eRT. "eRT's integrated enterprise
EDC platform, clinical information portal, and end-to-end clinical
data back office suite provide these organizations with a
singlesource solution to manage all key aspects of the clinical
trial process." Based in Philadelphia, PA, eResearchTechnology,
Inc. (http://www.ert.com/) is a provider of technology and services
to the pharmaceutical, biotechnology and medical device industries
on a global basis. The company is a market leader in providing
centralized core-diagnostic electrocardiographic (ECG) technology
and services to evaluate cardiac safety in clinical development.
The company is also a leader in providing technologyand services to
streamline the clinical trials process by enabling its customers to
automate the collection, analysis, and distribution of clinical
data in all phases of clinical development. Statements included in
this release may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as
competitive factors, technological development, market demand, and
the company's ability to obtain new contracts and accurately
estimate net revenues due to variability in size, scope and
duration of projects, and internal issues in the sponsoring client.
As a result, actual results may differ materially from any
financial outlooks stated herein. Further information on potential
factors that could affect the company's financial results can be
found in the company's Reports on Forms 10-K and 10-Q filed with
the Securities and Exchange Commission. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Joan Sterlacci of
eResearchTechnology, +1-908-203-6473, or Matt Hayden of Hayden
Communications, +1-760-487-1137, for eResearchTechnology Web site:
http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles